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Introduction
Helicobacter pylori is a stomach-colonizing Gram nega-
tive bacterium that infects more than half of the world’s 
 population.1,2 Because it increases the susceptibility to 
gastric cancer, associated with one of the highest mortality 
rates,3 it is classiﬁed as a Group 1 carcinogen by the World 
Health Organization.4 Moreover, it is associated with 95% of 
 duodenal ulcers and 80% of gastric ulcers.5 H. pylori colo-
nizes almost exclusively the stomach, lying deep in the mucus 
layer that covers the gastric epithelium,6 and also adhering to 
the surface of gastric epithelial cells and in deeper regions of 
the gastric glands (Figure 1a).7–9
The prevailing treatment for H. pylori eradication relies on 
a standard triple therapy, involving two antibiotics (clarithro-
mycin plus amoxicillin or metronidazole) combined with a 
proton pump inhibitor.10,11 Even with this triple therapy, full 
eradication fails in nearly 25% of the patients.12,13 This is 
caused by (i) the highly acidic gastric pH the drugs need to 
endure, (ii) the very viscous mucus the drugs have to perme-
ate,14 and (iii) the rising resistance of H. pylori to antibiotics.15 
 Therefore, alternative treatments are of utmost importance. 
To fulﬁl this need, antisense antibacterial therapy, through 
the use of oligonucleotides to inhibit the expression of essen-
tial bacterial genes, is a promising strategy.16–18 An attractive 
aspect of this approach is its ﬂexibility. In case microbial 
resistance emerges, commonly by point mutations,19 the 
oligonucleotides can be easily redesigned to target a new 
mutation, becoming an effective antibacterial again.
Conventional DNA oligonucleotides have relatively low 
afﬁnity toward RNA and DNA complementary sequences 
and are susceptible to degradation by endonucleases.20,21 
To overcome these drawbacks, nucleic acid mimics (NAMs), 
have emerged as alternatives.20,22 Among them, locked 
nucleic acids (LNA), 2’-Omethyl RNA (2’OMe) and phospho-
rothioate modiﬁed oligonucleotides (Figure 1b) have shown 
the most promising antisense in vivo.23–27 While nucleic acid 
therapy of bacterial infections is a relatively unexplored 
ﬁeld,18 delivery of oligonucleotides in bacteria is well stud-
ied to detect microorganisms based on ﬂuorescence in situ 
hybridization (FISH). FISH (Figure 1c) is based on speciﬁc 
base pairing, at high temperature, of an oligonucleotide with 
rRNA or mRNA target sequences, obeying to Watson-Crick 
hydrogen-bonding.28–31 Recently, Fontenete et al.32 have 
proven that oligonucleotides composed of both LNA and 
2’OMe (which we term LNA/2’OMe), with either phosphodi-
ester (PO) or phosphorothioate (PS) as backbone linkages, 
allow speciﬁc detection of H. pylori. In this work, well-reported 
agents to permeabilize the bacterial cell envelope (like para-
formaldehyde and ethanol) were used; H. pylori both grown in 
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culture as well as in gastric biopsies could be detected in this 
way at 37 °C. In addition, very recently, H. pylori detection by 
LNA/2’OMe (PS) oligonucleotides was successful even at a 
gastric pH and without the use of paraformaldehyde.33 How-
ever, the presence of gastric mucus was not addressed in 
these hybridization experiments.
Clearly, the success of in vivo hybridization (IVH) for treat-
ing H. pylori infection depends on the ability of the NAMs to 
overcome two main barriers: the gastric mucus and the bacte-
rial cell envelope (Figure 1a). Gastric mucus is a highly com-
plex and viscoelastic mixture that forms a major protective 
barrier for the penetration of particles.34 The rheological prop-
erties of the mucus are mostly determined by mucins, the 
main component of dry mucus, but also affected by the lipids, 
DNA, cells and cellular debris, proteins and ions present.34–37 
Having crossed the mucus layer, the next barrier encountered 
by the oligonucleotides will be the cell envelope of H. pylori. 
Unlike eukaryotic cells, which possess only a cell membrane, 
bacteria are protected from the outer environment by a 
multilayered cell envelope, composed of an inner membrane, 
periplasm, peptidoglycan layer and, in case of Gram negative 
bacteria, an outer membrane.38 Traditional FISH employs per-
meabilization agents to allow oligonucleotides to reach the 
cytoplasm.30 As these agents are typically toxic or noxious,39,40 
this step should be circumvented in future IVH therapies.
Considering the potential of IVH for treating H. pylori infec-
tion, we studied to which extent gastric mucus may be a bar-
rier for the delivery of oligonucleotides. More speciﬁcally, we 
studied (i) the (chemical) stability of LNA/2’OMe oligonucle-
otides in native gastric mucus scrapped off from porcine 
stomachs, (ii) the diffusion of LNA/2’OMe oligonucleotides, 
PO and PS, through the mucus, and (iii) the effect of gastric 
mucus on the efﬁciency of the ﬂuorescence in situ hybridiza-
tion in H. pylori. On top, we revealed to which extent the bac-
terial cell envelope is a barrier for the uptake of LNA/2’OMe 
oligonucleotides. Our experiments disclose important insights 
which will be of interest for the further development of gastric 
IVH therapies.
Figure 1  Illustration of nucleic acid mimics (NAMs) hybridization to H. pylori and the different components of the implemented 
model. (a) Schematic representation of NAMs in gastric mucus, on their way to target H. pylori. (b) Monomers of the NAMs used in 
fluorescence in situ hybridization (FISH), compared to RNA (adapted from32). (c) Illustration of the standard FISH procedure. PAR and ETH 
being paraformaldehyde and ethanol, respectively (adapted from ref. 30). (d) Procedure followed for the collection of native mucus from the 
stomach of pigs, obtained from the slaughterhouse. ETH, ethanol; PAR, paraformaldehyde.
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Results
NAMs uptake by H. pylori without prior permeabilization
For future H. pylori IVH therapy, ﬁxation and permeabilization 
of bacteria should be avoided as the reagents used are toxic or 
noxious. Therefore, we investigated the hybridization efﬁciency 
of LNA/2’OMe oligonucleotides without ﬁxation/permeabiliza-
tion of the bacteria (Figure 2). The hybridization was rather 
efﬁcient, as nearly 50% (PS) and 70% (PO) of the ﬂuorescence 
of the fully ﬁxed/permeabilized bacteria (treatment with both 
paraformaldehyde and ethanol) was achieved (Figure 2b). 
The treatment with ethanol alone did not have a real beneﬁt.
In Figure 2b, the hybridization and washing steps were 
performed at pH 7. In an in vivo setting, however, the hybrid-
ization will have to happen within the gastric mucus; note 
that the mucus samples we isolated from pigs showed an 
average pH of 5.8. In addition, highly acidic gastric juice in 
the gastric lumen (upwards the gastric mucus) might con-
tribute to wash away free NAMs. Therefore, we performed 
hybridization experiments at pH 5.8, followed by wash-
ing using simulated gastric juice (pH 1.8), instead of water 
(Figure 2c). It was veriﬁed that an efﬁcient uptake of the 
NAMs occurred without ﬁxation/permeabilization at neutral 
pH 7 (Figure 2b), as well as in conditions at pH closer to the 
in vivo (Figure 2c).
Diffusion of NAMs in native gastric mucus
Fluorescence recovery after photobleaching (FRAP) was 
used to measure the diffusion of both LNA/2’OMe oligo-
nucleotides in native porcine gastric mucus (Figure 3). As 
Figure 3b shows, when compared to 2-[4-(2-hydroxyethyl)
piperazin-1-yl]ethanesulfonic acid (HEPES) buffer, the diffu-
sion in gastric mucus was slowed down, especially for the 
PS oligonucleotides. As the f values reveal in Figure 3b, all 
PO oligonucleotides are mobile in mucus, while a small frac-
tion of the PS oligonucleotides becomes immobilized by the 
gastric mucus. Visual inspection of the microscopy images 
also showed a more heterogeneous distribution in mucus of 
PS, when compared to PO (Supplementary Figure S1 and 
Supplementary Movies in Supplementary Material).
Stability of NAMs in native gastric mucus
Polyacrylamide gel electrophoresis (PAGE) experiments 
reveal that both PO and PS oligonucleotides are stable in 
gastric mucus (Figure 4b). The faster diffusion of the PO in 
Figure 2 Effect of fixation/permeabilization of H. pylori on the hybridization efficiency by PS and PO. The combined use of 
paraformaldehyde (PAR) and ethanol (ETH) was compared to respectively the use of only ETH and no pretreatment of bacteria (no). 
Relative fluorescence being the fluorescence of the bacteria normalized to their fluorescence as measured in respective positive control 
(green bar). Results are presented as mean ± SEM, n = 3. Negative controls (i.e., without the use of oligonucleotides) (Neg) were included 
as well. (a) Representative epifluorescence microscopy images obtained with regular hybridization and washing at pH 7 and acquired 
at equal light exposure conditions. Scale bars represent 10 μm. (b) Regular hybridization and washing at pH 7. (c) Hybridization at the 
average pH found in the collected porcine gastric mucus (pH 5.8), followed by washing with simulated gastric juice without pepsin (pH 1.8). 
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mucus, compared to the PS oligonucleotides (as seen in Fig-
ure 3b), cannot be attributed to its enzymatic degradation, 
since it is stable and DNase and RNase resistant (Figure 4a).
Comparing each oligonucleotide in water and in mucus, we 
observed that gastric mucus “smeared” the oligonucleotides 
over the gel, thereby reducing the intensity of the oligonucle-
otide band (Figure 4b); this smearing was more pronounced 
in case of the PS oligonucleotides. Similar results were 
obtained using mucus from two other pigs. When incubating 
the oligonucleotides in a (commercial) mucin dispersion, the 
same trend was noticed (Figure 4c), although the smear-
ing of the oligonucleotides was less pronounced. The PAGE 
results suggest that the NAMs interact with mucus compo-
nents, likely mucins. In agreement with the outcome of the 
FRAP experiments (f values in Figure 3b), the PS oligo-
nucleotides seem to adhere more strongly to gastric mucus 
than the PO oligonucleotides.
H. pylori hybridization in native gastric mucus
To ﬁnd out whether the interactions between NAMs and 
mucus, as observed above, could affect the ability of NAMs 
to hybridize in H. pylori, FISH was performed with and without 
mucus in the hybridization step. Additionally, for each of these 
conditions, we tested both PAR-ETH treated and untreated 
bacteria (ETH treated was not considered at this stage, since 
it did not previously show a real effect on NAMs uptake). As 
shown in Figure 5, the presence of native gastric mucus 
signiﬁcantly decreased the hybridization efﬁciency of both 
NAMs, in ﬁxed/permeabilized and untreated H. pylori. When 
using ﬁxed/permeabilized H. pylori, a lower efﬁciency was 
noticed for PS than PO, in line with the previously observed 
stronger interaction of PS to mucus. This was not, however, 
reﬂected in untreated H. pylori (Figure 5b, orange bars). Also 
the mucin dispersion reduced the hybridization efﬁciency, but 
much less than native mucus (PS presented 55% and PO 
50% of the positive control’s ﬂuorescence), suggesting that 
mucin molecules alone do not fully explain the decreased 
hybridization in gastric mucus.
Discussion
LNA and 2’OMe oligonucleotides are promising nucleic acid 
mimics for novel gene therapies, due to their biological sta-
bility and improved target afﬁnity, compared to unmodiﬁed 
variants.25 Following the discovery of two LNA/2’OMe oli-
gonucleotides, one further modiﬁed with PS internucleotide 
linkages and another possessing normal PO linkages, able 
to speciﬁcally target H. pylori at human body temperature,32 
the present work aimed to reveal whether the LNA/2’OMe 
oligonucleotides hold promise to be used in vivo as anti-
sense strategy against H. pylori infections. Therefore, we 
Figure 3 Diffusion of NAMs in native gastric mucus. (a) A representative fluorescence recovery after photobleaching measurement on 
PO in porcine gastric mucus. The first frame shows the prebleach image. Next, a square region (30 × 30 μm) is bleached (at t = 0), followed 
by a time-lapse recording of the subsequent fluorescence recovery. (b) Average diffusion coefficient (D) and mobile fraction (f) of both NAMs 
in native gastric mucus normalized to their values in HEPES buffer. Results are presented as mean ± SEM, n = 3.  NAM, nucleic acid mimic; 
PO,  phosphodiester.
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investigated if LNA/2’OMe oligonucleotides can hybridize in 
H. pylori in the presence of native gastric mucus, without prior 
permeabilization and ﬁxation of the bacteria.
First, we investigated if LNA/2’OMe can penetrate the 
bacterial cell envelope without prior permeabilization and 
ﬁxation, employing FISH without mucus. Paraformaldehyde 
and ethanol are among the most common permeabiliza-
tion and ﬁxation agents.1,21,30,31,41–43 While paraformaldehyde 
is a ﬁxative, ethanol acts both as a ﬁxative and permea-
bilizer of the bacterial membrane lipids.44,45 Fixation and 
permeabilization agents cannot, however, be used for in 
vivo applications due to their toxicity.44 Our results showed 
successful hybridization of LNA/2’OMe oligonucleotides in 
untreated H. pylori, not only when hybridization and wash-
ing were performed at pH 7 (Figure 2b), but also under 
pH conditions representative for the in vivo gastric environ-
ment (Figure 2c). These ﬁndings are in line with a previous 
report, where it was shown that FISH targeting of bacterial 
rRNA can be performed without ﬁxation for identiﬁcation of 
bacteria in enhanced biological phosphorus removal sludge 
samples.46 Since the presence of ethanol by itself did not 
show a clear advantage in our hands (Figure 2), it can be 
concluded that permeabilization of the H. pylori envelope 
is not needed for the penetration of the LNA/2’OMe tested. 
The relatively small size of the oligonucleotides (10 mers) is 
certainly an advantage. One has to note, however, that the 
combined use of paraformaldehyde and ethanol did result in 
a stronger ﬂuorescence of the bacteria (Figure 2b,c). This 
may be due to a stronger ﬁxative effect of paraformaldehyde 
compared to ethanol, providing better preservation of ultra-
structures, proteins and nucleic acids and a longer main-
tenance of the ﬂuorescence, especially for gram negative 
bacteria.44,45,47
Next, we investigated the mobility and stability of 
LNA/2’OMe in native porcine gastric mucus. So far the pres-
ence of mucus has been neglected in relation to the delivery 
of macromolecules and antibiotics to H. pylori.12,48–50 On the 
other hand, several studies considering macromolecules/
particles diffusion in mucus use mimic models based on 
commercial mucins or mixtures thereof,51–54 which are still 
far from the real native gastric mucus. By PAGE, we could 
conﬁrm the integrity of both oligonucleotides in native gas-
tric mucus. In addition, by FRAP we found that gastric mucus 
is not a major diffusion barrier for the oligonucleotides, 
although the diffusion of PS in mucus was three times 
slower than in HEPES buffer, while for PO it was 1.2 times 
slower (DPS = 58.1 ± 8.1 μm2/s and DPO = 161.6 ± 8.0 μm2/s). 
This difference should not be attributed to the oligos’ size 
(since they differ only in 0.15 kDa), but to the presence of 
the thioate group (PS). This might lead to more or stron-
ger interactions of oligo PS with mucus components, likely 
mucins, since a similar interaction trend was observed in a 
suspension of commercial mucins, by PAGE. In any case, 
assuming an average thickness of the gastric mucus layer 
Figure 5 Effect of native gastric mucus on the hybridization efficiency by PS and PO. This effect was compared to the one of a mucin 
dispersion. H. pylori was fixed/permeabilized with paraformaldehyde and ethanol (images and green bars; PAR-ETH) or hybridized without any 
pretreatment (orange bars; no). Negative controls (in which no oligonucleotides were used; Neg) were included. (a) Representative epifluorescence 
microscopy images, acquired at equal light exposure conditions. Scale bars represent 10 μm. (b) and (c) Relative fluorescence being the 
fluorescence of the bacteria normalized to their fluorescence as measured when using the standard hybridization solution, without mucus or mucin 
dispersion. Results are presented as mean ± SEM, n = 3. PAR-ETH, paraformaldehyde–ethanol; PO,  phosphodiester; PS, phosphorothioate.
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of 180 μm,34 according to Equation 1 this means that cross-
ing this layer would take only 2 minutes for PO and less than 
5 minutes for PS.
t L
D
=
2
2
 
(1)
t being the time, L the thickness of mucus layer, and D the 
diffusion coefﬁcient.
Therefore, we conclude that the oligonucleotides are suf-
ﬁciently mobile in gastric mucus and can easily reach the 
bacteria which are present in the deeper layers of the mucus, 
adhered to the gastric epithelium.
In the presence of gastric mucus, the hybridization in H. 
pylori was signiﬁcantly hampered for both types of oligo-
nucleotides (Figure 5a,b), even at longer hybridization time 
(90 minutes instead of 30 minutes; results not shown), ruling 
out the possibility of diffusion being the limiting factor—even 
though that is not expected from the FRAP diffusion measure-
ments. It is clear that the mucus effect on hybridization was not 
masked by the dilution upon mixing with the oligonucleotides 
solution; actually, a relevant dilution may also occur in vivo, 
especially if a common administration by oral gavage is used. 
Hybridization within mucus must be hindered by interactions 
of the NAMs with mucus. Mucus is a complex mixture, com-
posed mainly of water and mucins, but also cellular debris, 
lipids, DNA, proteins, ions.34,37 Mechanisms of NAMs muco-
adhesion may include electrostatic interactions and multiple 
low-afﬁnity intermolecular bonds, as hydrophobic interactions 
and hydrogen bonds, given the increased amount of proton 
donors and acceptors in mucus.55 Adhesion of oligo PS was 
more evident than PO, likely due to the increased hydropho-
bicity of PS56 and possible establishment of disulﬁde bonds 
with mucins (mucins are formed by glycoprotein monomers 
cross-linked by disulﬁde bonds34,36,37), thereby explaining the 
slower diffusion of PS in mucus compared to PO. Interestingly, 
replacing mucus by a simple mucin suspension did partially 
restore hybridization (Figure 5c). This shows that hybridiza-
tion in mucus is not simply hindered due to interaction of the 
oligonucleotides with mucins, but rather with other mucus 
constituents, as well. Although the particular role/identity of 
mucus components in the interaction with NAMs remains 
unclear at this time, soluble factors must account for it, as 
the FRAP experiments did not show substantial immobiliza-
tion (i.e., f > 0.9). A corollary of the mucin experiment is that 
clearly a simple mucin dispersion is not a sufﬁciently accurate 
model for gastric mucus and may lead to misleading conclu-
sions when used alone. Another factor that might contribute 
to decreased hybridization in the presence of mucus is that 
binding of H. pylori to mucins, which has been reported in the 
colonization of the stomach,57,58 may decrease its membrane 
surface area available for the NAMs penetration.
Taken together, our study points out that situ hybridization 
of LNA/2’OMe does not require permeabilization of the cell 
envelope, which is beneﬁcial towards potential future IVH 
therapies. On the other hand, while neither NAMs stability 
is a concern nor their diffusion through native gastric mucus 
is a major obstacle, binding interactions with mucus compo-
nents other than mucins reduced the hybridization efﬁciency. 
This work reveals the importance of considering the effect of 
a representative, native, undiluted, gastric mucus on NAMs 
delivery to mucosal sites. Future work should focus on devel-
oping strategies that protect LNA/2’OMe from interacting 
with mucus components while traveling through the mucus 
layer. One interesting approach could be the incorporation 
of LNA/2’OMe into suitable nanocarriers, such as fusogenic 
liposomes, that shield the oligonucleotides from the environ-
ment, while being able to deliver them efﬁciently into the cells.
Materials and Methods
Isolation of gastric mucus. Native gastric mucus from the 
stomach of pigs was used in this study, since porcine gas-
tric mucus is considered a suitable model for human gastric 
mucus.37,51 Moreover, pigs have a gastric physiology similar 
to humans, making them representative animal models for 
studies of Helicobacter infection.59
Mucus from three different pigs was included in each 
assay. Stomachs were collected from a slaughterhouse and 
immediately opened at the major curvature and rinsed with 
tap water.60 The mucus from the antrum region was then 
gently scrapped off using a glass slide and placed in a 
sterile tube (Figure 1d). Each tube was then aliquoted, plac-
ing 200 μl into sterile Eppendorf vials with a sterile plastic 
syringe, and stored at −80 °C.
Synthesis of NAMs. Two oligonucleotides, named HP_
LNA/2OMe_PS and HP_LNA/2OMe_PO,32 complementary 
to a sequence of the H. pylori 16S rRNA gene, were used 
in this study. These are composed of LNA and 2’OMe, pos-
sess the same sequence and differ only in the internucleotide 
bonds. One possesses normal phosphodiester oligonucle-
otides (PO), while the other has one of the two nonbridging 
oxygen atoms replaced by a sulfur atom at each internucleo-
tide linkage (PS) (Figure 1b). To simplify, these oligonucle-
otides will be herein designated as PO and PS, respectively. 
The sequence of PO is 5’-lGmeAmeClTmeAmeAlGmeCme-
ClC-3’, while the sequence of PS is 5’-lG*meA*meC*lT*me
A*meA*lG*meC*meC*lC*-3’, where “l” represents the LNA 
monomers, “me” the 2’OMe monomers and * the phospho-
rothioate linkages. Oligonucleotides labeled at 5’ with ﬂuo-
rescein phosphoramidite (FAM, Glen Research, VA) were 
synthetized and puriﬁed according to ref. 32. The same oligo-
nucleotides labeled at the 5’-terminal with Cy3 were acquired 
from Eurogentec (Ougrée, Belgium).
Measuring the diffusion of NAMs in native gastric mucus 
by FRAP. Approximately 30 μl of native (undiluted) gastric 
mucus was taken with a plastic syringe and mixed with 4 μl 
of 100 μmol/l FAM-labeled PO or PS. The mixture was then 
placed on a microscopy glass slide sealed with an adhesive 
spacer (S24735, Secure-Seal, Life Technologies, Paisley, 
UK) and a cover slip. The sample was placed in a stage top 
incubation chamber (Tokai Hit, Shizuoka, Japan), to perform 
measurements at 37 °C. Mucus from three different pigs was 
tested and for each mucus-NAM sample the diffusion mea-
surements were done in triplicate. Measurements in HEPES 
buffer were performed as control.
www.moleculartherapy.org/mtna
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FRAP was used to measure the diffusion of the ﬂuorescently 
labeled oligonucleotides.61,62 For a detailed description of the 
FRAP experiments, we refer to a previous publication from our 
group.61 The measurements were performed using a Nikon 
C1si confocal laser scanning microscope (CLSM), equipped 
with a Plan Apo 10x NA 1.4 objective lens. The 488 nm argon 
ion laser (CVI Melles Griot, CA) was used for photobleaching 
and imaging. In brief, a FRAP experiment occurs as follows. 
Using a strong laser beam the ﬂuorescence in a rectangular 
area (30 × 30 μm) of the mucus-NAM sample is bleached. Next, 
using an attenuated laser beam, a time-lapse image series is 
recorded to visualize the ﬂuorescence recovery in the bleached 
area which is due to diffusion of the ﬂuorescent NAMs from 
the (nonbleached) surrounding into the bleached zone (see 
Figure 3a). The local diffusion coefﬁcient (D) and the fraction 
of mobile (f) and immobile oligonucleotides can be calculated 
by ﬁtting the ﬂuorescence recovery data to a theoretical model 
(Supplementary Materials and Methods), as developed in 
our group by Deschout et al. 62
Measuring the stability of NAMs in native gastric mucus by 
PAGE. Two microliters of 20 μmol/l PS or PO (labeled with 
FAM) were gently mixed (using a 1,000 μl pipette tip) with 
approximately 5 μl of porcine gastric mucus and incubated 
at 37 °C for 10 minutes (the approximate time needed for a 
FRAP measurement). Loading buffer (2 μl of Ambion gel load-
ing solution, Life Technologies, Paisley, UK) was then mixed 
with the mucus-NAM sample. FAM-labeled oligonucleotides 
alone and mucus alone were run as controls on a PAGE gel. 
Each empty well on the gel was ﬁlled with a blank (a mixture 
of 7 μl milli-Q water and 2 μl of loading buffer). In addition, the 
stability of PS and PO was tested in a suspension of com-
mercial mucin from porcine stomach (type II, Sigma-Aldrich, 
Bornem, Belgium). Therefore, PS and PO were incubated in 
a 3% (w/v) mucin dispersion (in 0.9% (w/v) NaCl solution).63,64
To investigate the degradation of the oligonucleotides by 
nucleases, PO was incubated for 2 hours at 37 °C with DNase 
(TURBO DNase, Life Technologies) and RNase (RNase A, 
Qiagen Benelux B.V., Venlo, The Netherlands). The reaction 
mixture contained 4 μl of a 5 μmol/l PO, 1 μl of DNase (2U) or 
RNase (7U) and 13 μl of the respective supplied reaction buffer.
All the samples were loaded onto 20% nondenaturing poly-
acrylamide gels prepared in 5× TBE buffer. Electrophoresis 
was performed at 110 V, during 75 minutes. Thereafter, the 
ﬂuorescently labeled oligonucleotides on the gels were visu-
alized by UV transillumination and gel photography.
H. pylori FISH—NAMs uptake and hybridization in native 
gastric mucus. H. pylori 26695 (ATCC 700392) was grown 
in trypticase soy agar (TSA) supplemented with 5% sheep 
blood (Becton Dickinson GmbH, Germany) for 48 hours, 
at 37 °C, under microaerobic conditions. The biomass was 
recovered from the plates using sterile saline (0.9% (w/v) 
NaCl) and diluted to nearly 1 × 106 colony-forming unit (CFU)/
ml. Smears were prepared on glass slides (20 μl per slide 
well) by drying at 37 °C. FISH on slide was performed accord-
ing to Fontenete et al.32,33, with slight modiﬁcations. The 
main steps of standard FISH are schematically presented 
in Figure 1c. For standard ﬁxation/permeabilization, the 
smears were ﬁrst immersed in 4% (w/v) paraformaldehyde 
(Fluka—Sigma-Aldrich) for 10 minutes, followed by 15 min-
utes in 50% (v/v) ethanol (Fluka—Sigma-Aldrich) and allowed 
to dry. To test the role of ﬁxation/permeabilization on hybrid-
ization efﬁciency, samples treated only with ethanol, and 
samples not ﬁxed/permeabilized at all were included. The 
smears were then covered with 20 μl hybridization solution 
containing 500 mmol/l urea (Vel—VWR, Haasrode, Belgium), 
500 mmol/l Tris-HCl, pH 7 (Sigma-Aldrich), 900 mmol/l NaCl 
(Sigma-Aldrich), and 400 nmol/l of PS or PO labeled with 
Cy3. To test the effect of native gastric mucus on hybridiza-
tion efﬁciency, approximately 30 μl of gastric mucus was ﬁrst 
mixed with 20 μl of hybridization solution, and then applied on 
the bacteria smear (note that the ﬁnal concentration of NAMs 
and hybridization solution applied on the bacteria were kept 
the same as in standard FISH). Samples were covered with 
a coverslip, placed in dark moist chambers and allowed to 
hybridize during 30 minutes, at 37 °C. The coverslips were 
then removed, together with the mucus mixture (when pres-
ent). To avoid nonﬁxed H. pylori to be removed from the slide 
together with the mucus mixture, slides coated with 0.1% 
(w/v) Poly-L-lysine (Sigma-Aldrich) were used for better 
adhesion of H. pylori. The slides were then washed during 
15 minutes using warm (37 °C) water at pH 7, allowed to 
dry and visualized on the microscope. The experiments were 
performed using gastric mucus from three different pigs, in 
triplicate. The effect of native gastric mucus was compared 
with that of a mucin dispersion, by performing hybridization in 
the presence of a 3% (w/v) suspension of commercial mucin 
(from porcine stomach), instead of mucus. In addition, the 
inﬂuence of acidic washing with simulated gastric juice with-
out pepsin (sGJ; 0.2% w/v NaCl, 80 mmol/l HCl, pH 1.8, ref. 
65) was evaluated, after hybridization at the same average 
pH found in the collected porcine gastric mucus (pH 5.8). 
Negative controls using hybridization solution without oligo-
nucleotides, and maintaining the remaining FISH conditions, 
were performed in all experiments.
Microscopy images were acquired using a Nikon TE2000 
microscope equipped with a Nikon DS-Qi 1Mc epiﬂuores-
cence camera and a Plan Apo VC 100 × 1.4 NA oil immersion 
objective lens (Nikon). Cy3 ﬂuorescence was visualized using 
a TRITC ﬁlter (excitation: 530–560 nm; emission: 590–650 nm, 
Nikon). The same exposure time and the same intensity of 
the ﬂuorescent lamp were used for all the samples. For ﬂuo-
rescence quantiﬁcation, 10–15 images per well were taken 
randomly, covering all the areas of the slide well.
Quantiﬁcation of H. pylori hybridization. The hybridization 
efﬁciency in the different conditions was compared through 
quantiﬁcation of the ﬂuorescence intensity. This was done 
using image processing routines available in Matlab (The 
MathWorks, Natick, MA). First, bacteria were identiﬁed in 
each image based on an automatically determined inten-
sity threshold. After removal of remaining noise (by select-
ing areas with a minimum number of pixels), a binary mask 
was generated that corresponds to the location of bacteria in 
the image. For the regions within the mask, the ﬂuorescence 
intensity in the original image was quantiﬁed as
Intensity int BG pixb b= −( ) ×⎡⎣ ⎤⎦∑
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where intb corresponds to the ﬂuorescence intensity of 
each bacterium, BG the background value and pixb the num-
ber of pixels of the bacterium.
Per condition, 10 to 15 images were analyzed in this 
fashion from which the average ﬂuorescence intensity was 
calculated. These absolute values were normalized to the 
respective positive control of PS or PO, hybridized in hybrid-
ization solution and washed with water or sGJ.
Statistical analysis. Statistical analysis was performed by 
GraphPad Prism6 software (GraphPad Software, San Diego, 
CA). FISH results were analyzed using two-way analysis 
of variance and Tukey’s multiple comparison test, com-
paring the conditions within the same NAM. FRAP results 
were analyzed by one-way analysis of variance and Sidak’s 
multiple comparisons test. Signiﬁcance was set at P ≤ 0.05 
(****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05).
Supplementary Material
Figure S1. Confocal images of porcine gastric mucus after 
mixing with respectively PS and PO oligonucleotides. Images 
from FRAP experiments prior to bleaching.
Supplementary Materials and Methods.
Supplementary References.
Supplementary movie PS. Representative FRAP movie of 
PS in native gastric mucus.
Supplementary movie PO. Representative FRAP movie of 
PO in native gastric mucus.
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